WEKO3
-
RootNode
アイテム
医薬品企業の収益性に関する一考察 : 武田薬品工業と中外製薬の比較研究《研究ノート》
https://doi.org/10.24561/00017000
https://doi.org/10.24561/00017000fb0c5fc2-cbd1-4a7f-abe2-cacf514b0748
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
公開日 | 2013-12-10 | |||||||||
タイトル | ||||||||||
タイトル | 医薬品企業の収益性に関する一考察 : 武田薬品工業と中外製薬の比較研究《研究ノート》 | |||||||||
言語 | ||||||||||
言語 | jpn | |||||||||
キーワード | ||||||||||
主題Scheme | Other | |||||||||
主題 | profitability analysis | |||||||||
キーワード | ||||||||||
主題Scheme | Other | |||||||||
主題 | management capital | |||||||||
キーワード | ||||||||||
主題Scheme | Other | |||||||||
主題 | ratio of profit to net sales | |||||||||
キーワード | ||||||||||
主題Scheme | Other | |||||||||
主題 | rate of management capital turnover | |||||||||
資源タイプ | ||||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||
資源タイプ | departmental bulletin paper | |||||||||
ID登録 | ||||||||||
ID登録 | 10.24561/00017000 | |||||||||
ID登録タイプ | JaLC | |||||||||
タイトル(別言語) | ||||||||||
その他のタイトル | Profitability Analysis of Japanese Pharmaceutical Companies : Comparative Study on Takeda Pharmaceutical and Chugai Pharmaceutical | |||||||||
著者 |
金子, 秀
× 金子, 秀
|
|||||||||
著者 ローマ字 | ||||||||||
値 | KANEKO, Shigeru | |||||||||
著者 所属 | ||||||||||
値 | 埼玉大学経済学部 | |||||||||
著者 所属(別言語) | ||||||||||
値 | Faculty of Economics, Saitama University | |||||||||
書誌情報 |
社会科学論集 en : SHAKAIKAGAKU-RONSHU (The Social Science Review) 巻 140, p. 61-86, 発行日 2013 |
|||||||||
年月次 | ||||||||||
値 | 2013-11 | |||||||||
出版者名 | ||||||||||
出版者 | 埼玉大学経済学会 | |||||||||
出版者名(別言語) | ||||||||||
出版者 | The Economics Society of Saitama University | |||||||||
ISSN | ||||||||||
収録物識別子タイプ | ISSN | |||||||||
収録物識別子 | 05597056 | |||||||||
概要 | ||||||||||
内容記述タイプ | Other | |||||||||
内容記述 | The Japanese government suggests that the health industry is a growing industry. In particular, pharmaceutical and medical equipment industries are significant sectors of the health industry. The author agrees, but can Japanese pharmaceutical companies compete? This paper looks at two companies (Takeda Pharmaceutical Co., Ltd. and Chugai Pharmaceutical Co., Ltd.) and examines their profitability between 2004 and 2011. The paper focuses on management capital which is a value driver of total capital. The findings are as follows. Takeda is based on small molecule drugs which are not related to unmet medical needs. As a result, the Rate of Return on Assets (ROA) for Takeda is in an alarming decline. On the other hand, Chugai is based on big molecule drugs which are related to unmet medical needs. Chugai is under the control of F. Hoffman-La Roche Ltd., and it introduces bio drugs. Therefore, the ROA for Chugai has been constant for 8 years. Why is the Takeda ROA in decline? This paper researches the factor of profitability (profitability analysis). In Takeda, both the ratio of profit to net sales and the rate of management capital turnover are in decline. Takeda has not developed new innovative drugs. In the case of Chugai, not only the ratio of profit to net sales but also the rate of management capital turnover are generally constant because Chugai introduces bio drugs through the Roche group. In the future, the success of the two companies depends on their R&D capability to develop innovative drugs. |
|||||||||
目次 | ||||||||||
内容記述タイプ | Other | |||||||||
内容記述 | 1.本研究の課題と方法 2.医薬品企業の収益モデル 3.医薬品企業における「収益性の分析」 4.研究開発と収益性 5.結論 |
|||||||||
版 | ||||||||||
値 | [出版社版] | |||||||||
著者版フラグ | ||||||||||
出版タイプ | VoR | |||||||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||
資源タイプ | ||||||||||
内容記述タイプ | Other | |||||||||
内容記述 | text | |||||||||
フォーマット | ||||||||||
内容記述タイプ | Other | |||||||||
内容記述 | application/pdf | |||||||||
作成日 | ||||||||||
日付 | 2013-12-09 | |||||||||
日付タイプ | Created | |||||||||
アイテムID | ||||||||||
値 | KY-AN00109186-140-08 |
Share
Cite as
金子, 秀, 2013, 医薬品企業の収益性に関する一考察 : 武田薬品工業と中外製薬の比較研究《研究ノート》: 埼玉大学経済学会, 61–86 p.
Loading...